C4 THERAPEUTICS INC (CCCC) Institutional Shareholders
C4 THERAPEUTICS INC (CCCC) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $547.63M in CCCC holdings during the latest filing period.
Morgan Stanley is currently the largest disclosed institutional shareholder of CCCC tracked by InsiderSet, reporting ownership valued at approximately $41.41M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $30.06M, representing an estimated loss of -27.41% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 54% of the total disclosed CCCC value among the investors covered in this analysis. Major shareholders include Morgan Stanley, Ra Capital Management, L.P., Blackrock, Inc., and several other long-term asset managers with concentrated positions in C4 THERAPEUTICS INC (CCCC).
This page ranks the largest institutional CCCC shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
147
Total Reported Value
$547.63M
Largest Holder
Morgan Stanley
Largest Position
$41.41M
Insider Transactions (90d)
4
Latest Filing Quarter
Q2 2026
New Institutional Positions
147
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 0.00% | 8,867,338 | $41,410,468 | $30,060,276 | -$11,350,192 | -27.41% | |
| Ra Capital Management, L.P. | 0.32% | 8,000,000 | $37,360,000 | $27,120,000 | -$10,240,000 | -27.41% | |
| Blackrock, Inc. | 0.00% | 7,896,718 | $36,877,672 | $26,769,874 | -$10,107,798 | -27.41% | |
| Lynx1 Capital Management Lp | 3.95% | 7,326,691 | $34,215,647 | $24,837,482 | -$9,378,165 | -27.41% | |
| Squadron Capital Management Llc | 11.51% | 7,200,000 | $33,624,000 | $24,408,000 | -$9,216,000 | -27.41% | |
| Bain Capital Life Sciences Investors, Llc | 1.99% | 7,171,910 | $33,492,820 | $24,312,775 | -$9,180,045 | -27.41% | |
| Jpmorgan Chase & Co | 0.00% | 4,747,424 | $20,651,295 | $16,093,767 | -$4,557,528 | -22.07% | |
| Vanguard Capital Management Llc | 0.00% | 4,417,731 | $20,630,804 | $14,976,108 | -$5,654,696 | -27.41% | |
| Citadel Advisors Llc | 0.01% | 4,187,580 | $19,555,999 | $14,195,896 | -$5,360,103 | -27.41% | |
| Goldman Sachs Group Inc | 0.00% | 3,530,991 | $16,489,728 | $11,970,059 | -$4,519,669 | -27.41% | |
| Wasatch Advisors Lp | 0.11% | 3,522,644 | $16,450,747 | $11,941,763 | -$4,508,984 | -27.41% | |
| Two Sigma Investments, Lp | 0.01% | 3,469,707 | $16,203,532 | $11,762,307 | -$4,441,225 | -27.41% | |
| Soleus Capital Management, L.P. | 0.54% | 3,377,981 | $15,775,171 | $11,451,356 | -$4,323,815 | -27.41% | |
| Silverarc Capital Management, Llc | 1.58% | 3,032,060 | $14,159,720 | $10,278,683 | -$3,881,037 | -27.41% | |
| Bank Of America Corp | 0.00% | 2,656,359 | $12,405,197 | $9,005,057 | -$3,400,140 | -27.41% | |
| Geode Capital Management, Llc | 0.00% | 2,522,163 | $11,780,697 | $8,550,133 | -$3,230,564 | -27.42% | |
| Ikarian Capital, Llc | 1.86% | 2,433,000 | $11,362,110 | $8,247,870 | -$3,114,240 | -27.41% | |
| State Street Corp | 0.00% | 2,115,621 | $9,879,950 | $7,171,955 | -$2,707,995 | -27.41% | |
| Acadian Asset Management Llc | 0.01% | 1,806,199 | $8,429,000 | $6,123,015 | -$2,305,985 | -27.36% | |
| Candriam S.C.A. | 0.04% | 1,796,937 | $8,383,622 | $6,091,616 | -$2,292,006 | -27.34% | |
| D. E. Shaw & Co., Inc. | 0.01% | 1,740,989 | $8,130,419 | $5,901,953 | -$2,228,466 | -27.41% | |
| Susquehanna International Group, Llp | 0.01% | 1,732,210 | $8,089,421 | $5,872,192 | -$2,217,229 | -27.41% | |
| Patient Square Capital Lp | 1.16% | 1,608,815 | $7,513,166 | $5,453,883 | -$2,059,283 | -27.41% | |
| Highvista Strategies Llc | 1.44% | 1,348,136 | $6,295,800 | $4,570,181 | -$1,725,619 | -27.41% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 1,189,828 | $5,556,497 | $4,033,517 | -$1,522,980 | -27.41% |
| Dimensional Fund Advisors Lp | 0.00% | 1,188,507 | $5,546,166 | $4,029,039 | -$1,517,127 | -27.35% | |
| Northern Trust Corp | 0.00% | 1,160,547 | $5,419,754 | $3,934,254 | -$1,485,500 | -27.41% | |
| Congress Asset Management Co | 0.03% | 1,003,437 | $4,686,051 | $3,401,651 | -$1,284,400 | -27.41% | |
| Fmr Llc | 0.00% | 894,054 | $4,175,231 | $3,030,843 | -$1,144,388 | -27.41% | |
| Ubs Group Ag | 0.00% | 828,970 | $3,871,289 | $2,810,208 | -$1,061,081 | -27.41% | |
| Charles Schwab Investment Management Inc | 0.00% | 781,060 | $3,647,550 | $2,647,793 | -$999,757 | -27.41% | |
| Boothbay Fund Management, Llc | 0.06% | 736,331 | $3,438,666 | $2,496,162 | -$942,504 | -27.41% | |
| Vanguard Portfolio Management Llc | 0.00% | 680,094 | $3,176,039 | $2,305,519 | -$870,520 | -27.41% | |
| Vanguard Fiduciary Trust Co | 0.00% | 609,146 | $2,844,712 | $2,065,005 | -$779,707 | -27.41% | |
| Exoduspoint Capital Management, Lp | 0.03% | 580,195 | $2,709,511 | $1,966,861 | -$742,650 | -27.41% | |
| Velan Capital Investment Management Lp | 1.63% | 570,000 | $2,661,900 | $1,932,300 | -$729,600 | -27.41% | |
| Stempoint Capital Lp | 0.42% | 523,648 | $2,445,436 | $1,775,167 | -$670,269 | -27.41% | |
| Rockefeller Capital Management L.P. | 0.00% | 495,817 | $2,315,465 | $1,680,820 | -$634,645 | -27.41% | |
| Nuveen, Llc | 0.00% | 484,010 | $2,260,326 | $1,640,794 | -$619,532 | -27.41% | |
| Wells Fargo & Company/Mn | 0.00% | 452,701 | $2,114,113 | $1,534,656 | -$579,457 | -27.41% | |
| Man Group Plc | 0.00% | 408,648 | $1,908,386 | $1,385,317 | -$523,069 | -27.41% | |
| Platinum Investment Management Ltd | 0.44% | 384,766 | $1,796,857 | $1,304,357 | -$492,500 | -27.41% | |
| Seven Fleet Capital Management Lp | 0.29% | 381,169 | $1,780,059 | $1,292,163 | -$487,896 | -27.41% | |
| Qube Research & Technologies Ltd | 0.00% | 370,554 | $1,730,487 | $1,256,178 | -$474,309 | -27.41% | |
| Atom Investors Lp | 0.15% | 364,351 | $1,701,519 | $1,235,150 | -$466,369 | -27.41% | |
| Susquehanna Portfolio Strategies, Llc | 0.02% | 335,079 | $1,564,819 | $1,135,918 | -$428,901 | -27.41% | |
| Adage Capital Partners Gp, L.L.C. | 0.00% | 325,000 | $1,517,750 | $1,101,750 | -$416,000 | -27.41% | |
| Jane Street Group, Llc | 0.00% | 302,750 | $1,413,843 | $1,026,323 | -$387,521 | -27.41% | |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | 300,734 | $1,404,428 | $1,019,488 | -$384,940 | -27.41% | |
| Adar1 Capital Management, Llc | 0.06% | 291,957 | $1,363,439 | $989,734 | -$373,705 | -27.41% |
Frequently asked questions about CCCC
Who owns the most CCCC stock?
The largest holders of CCCC are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for C4 THERAPEUTICS INC (CCCC).
Is CCCC widely held by superinvestors?
Many widely followed stocks like CCCC appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CCCC is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.